Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 187 | 181 | −6 |
| Shares | 67.0M | 68.6M | +1.57M (+2.3%) |
| Value | $2.74B | $2.56B | −$178.2M (−6.5%) |
New holders (20)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 98,356 | $3.67M | 0.08% |
| Employees Retirement System of Texas | 97,500 | $3.63M | 0.04% |
| Pura Vida Investments, LLC | 52,213 | $1.95M | 0.15% |
| HRT Financial LP | 39,041 | $1.46M | 0.01% |
| Lazard Asset Management LLC | 31,525 | $1.18M | 0.00% |
| Dynamic Technology Lab Private Ltd | 21,780 | $812.0K | 0.10% |
| Tudor Investment Corp Et Al | 18,678 | $696.0K | 0.01% |
| Oppenheimer Asset Management Inc. | 16,030 | $598.0K | 0.01% |
| HAP Trading, LLC | 14,460 | $539.0K | 0.04% |
| Old Mission Capital LLC | 12,118 | $452.0K | 0.02% |
| LMR Partners LLP | 12,000 | $447.0K | 0.01% |
| Ergoteles LLC | 11,400 | $425.0K | 0.02% |
| Rafferty Asset Management, LLC | 9,549 | $356.0K | 0.00% |
| Advisory Research Inc | 7,939 | $296.0K | 0.02% |
| Wolverine Trading, LLC | 8,090 | $290.0K | 0.01% |
| ExodusPoint Capital Management, LP | 6,859 | $256.0K | 0.00% |
| Centiva Capital, LP | 5,561 | $207.0K | 0.02% |
| Atwood & Palmer Inc | 600 | $22.0K | 0.00% |
| Meridian Wealth Partners, LLC | 20 | $1.00K | 0.00% |
| Bell Investment Advisors, Inc | 15 | $1.00K | 0.00% |
Sold out (26)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.